S100B and Alzheimer disease: Increased S100B cerebrospinal fluid levels were also reported in Parkinson's disease (Sathe et al., 2012), Alzheimer's disease (Edwards and Robinson, 2006), and schizophrenia (Schmitt et al., 2005), implying roles for S100B in the pathogenesis of neurodegenerative diseases.